Journal of Immunotoxicology

Top Research Topics at Journal of Immunotoxicology?

The discussions in the journal mainly cover the fields of Immunology, Immune system, Internal medicine, Pharmacology and Endocrinology. Cytokine, Antigen, Inflammation, Antibody and Interleukin are some of the study areas of Immunology discussed. The Interleukin study featured in the journal draws parallels with the field of Tumor necrosis factor alpha.

It explores research in Tumor necrosis factor alpha and the adjacent study of Lipopolysaccharide. The concepts on Immune system presented in the journal can also apply to other research fields, including Spleen and Toxicity. Studies on Pharmacology discussed in it link to the field of In vitro.

In vitro research discussed connects with the study of In vivo.

• Immunology (57.60%)
• Immune system (36.02%)
• Internal medicine (16.26%)

What are the most cited papers published in the journal?

• Immunogenicity of therapeutic proteins: Influence of aggregation (344 citations)
• Immune suppression as related to toxicology. (283 citations)
• β-Glucans, History, and the Present: Immunomodulatory Aspects and Mechanisms of Action (229 citations)

Research areas of the most cited articles at Journal of Immunotoxicology:

The published articles focus on Immunology, Immune system, Antibody, Cytokine and Antigen. The studies on Immunology discussed at the journal papers can also contribute to research in the domains of Cytotoxic T cell, Internal medicine and Apoptosis. The most cited articles explore issues in Antibody which can be linked to other research areas like C57BL/6 and T cell.

What topics the last edition of the journal is best known for?

• Internal medicine
• Immune system
• Gene

The previous edition focused in particular on these issues:

Journal of Immunotoxicology focuses on Immune system, Immunology, Inflammation, Cytokine and Internal medicine. Immune system research presented in the journal encompasses a variety of subjects, including Anesthetic gases, Health care and Intensive care medicine. It explores topics in Immunology which can be helpful for research in disciplines like Prospective cohort study and Birth cohort.

In it, Cholinergic, Interleukin, Lipid metabolism, Type 2 diabetes and Dysbiosis are investigated in conjunction with one another to address concerns in Inflammation research. Issues in Cytokine were discussed, taking into consideration concepts from other disciplines like Microbiome, Stroma, Homeostasis, Allergen and Sensitization. Topics in Internal medicine were tackled in line with various other fields like Ex vivo, Endocrinology, Inhalation and Lactobacillus plantarum.

The most cited articles from the last journal are:

• From nicotine to the cholinergic anti-inflammatory reflex - Can nicotine alleviate the dysregulated inflammation in COVID-19? (3 citations)
• Immune activation by microbiome shapes the colon mucosa: Comparison between healthy rat mucosa under conventional and germ-free conditions. (1 citations)
• In vitro prediction of in vivo pseudo-allergenic response via MRGPRX2. (1 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Journal of Immunotoxicology (based on the number of publications) are:

• Thomas T. Kawabata (17 papers) absent at the last edition,
• Kimber L. White (16 papers) absent at the last edition,
• Jack Uetrecht (15 papers) absent at the last edition,
• Stacey E. Anderson (15 papers) absent at the last edition,
• Dori R. Germolec (14 papers) published 1 paper at the last edition, 1 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Immunotoxicology (based on the number of publications) are:

• Pfizer (33 papers) absent at the last edition,
• National Institute for Occupational Safety and Health (27 papers) absent at the last edition,
• University of Toronto (17 papers) absent at the last edition,
• National Institutes of Health (16 papers) published 1 paper at the last edition, 1 less than at the previous edition,
• Research Triangle Park (16 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 6.67% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 14.29% were posted by at least one author from the top 10 institutions publishing in the journal. Another 14.29% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 7.14% of all publications and 64.29% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.